Panel probit models: Dummy variable which takes a value of 1 for a top 5 publication. by Sergey V. Popov (6719075)

Delayed boosting with ALVAC-HIV/AIDSVAX B/E or AIDSVAX B/E increases V1V2-specific IgG concentration and breadth. by LaTonya D. Williams (3140490)

Magnitude-breadth of linear V2 hotspot binding response. by LaTonya D. Williams (3140490)

Pyrimidine nucleotides are decreased in hypoxia, while precursors accumulate. by Emily B. Cohen (9106088)

GSK343 decreased neuroblastoma viability, proliferation, and motility. by Laura V. Bownes (10276762)

“…<p>(A) SK-N-AS, SK-N-BE(2), SH-EP and WAC(2) cells (1.5 × 10³ cells) were treated with increasing concentrations of GSK343 (0, 5, 15, 25 μM) for 24 hours and viability was measured using alamarBlue^® assay. …”

Bortezomib decreases osteoclasts and improves fracture repair in mice. by Hengwei Zhang (2397610)

Foldases and holdases each decrease the level of unfolded protein. by Adam MR de Graff (9767829)

Germ cell size decreases before corpse formation. by Tea Kohlbrenner (19476160)

MMR mutants show decreased mating-type silencing. by Qian Liu (135614)

“…Cells were five-fold serially diluted and grown at 30℃ followed by storage in 4℃ until clear red pigment formation could be seen (15 days). …”

Dynamin inhibitors decrease the viability of acute leukemia cells. by Christopher von Beek (11401835)

<i>son</i> reduction decreases T cell numbers. by Rebecca L. Belmonte (8384103)

Yta4 decreases the affinity of Dnm1 for GTP. by Jiajia He (795335)

Coordinates of A_i and B_i points in cylindrical coordinate system. by Weiliang Zhang (11231646)

HFD induces LDs and decreases ER and mitochondria in nephrocytes. by Aleksandra Lubojemska (10746241)

“…(<b>E</b>) Low and high magnification views of pericardial nephrocytes (dotted outlines) from STD and HFD larvae, showing that HFD decreases mitochondria (marked with anti-ATP5A) and ER (marked with anti-KDEL) but increases LDs (marked with LipidTOX). …”

The combination of LPS and PFC caused faster clot initiation and decreased clot strength. by Heather F. Pidcoke (9023789)

“…Comparing groups, there is a significant decline in TEG MA in LPS-PFC3 group compared to LPS-SAL group at T72 and T96 time points (p<0.05). …”

Osteogenic differentiation of mesenchymal stem cells is enhanced in a 45S5-supplemented β-TCP composite scaffold: an <i>in-vitro</i> comparison of Vitoss and Vitoss BA - Fig 3 by Fabian Westhauser (5314436)

Role of Ser77 in ACER3 catalytic site. by Jae Kyo Yi (13570063)

Linearity of ACER3 activity assay. by Jae Kyo Yi (13570063)

Determinants of decrease in COVID-19 immunity among vaccinated patients over a 6-month period using univariate analysis and multivariable logistic regression models. by Dalal Nour (18530615)

The kinetics of ACER3 and mutants. by Jae Kyo Yi (13570063)